A BILL 
To amend title XI of the Social Security Act to provide 
greater transparency for discounts provided by manufac-
turers. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Improving Trans-
4
parency to Lower Drug Costs Act of 2021’’. 
5
SEC. 2. PUBLIC DISCLOSURE OF DRUG DISCOUNTS. 
6
Section 1150A of the Social Security Act (42 U.S.C. 
7
1320b–23) is amended— 
8
17:16 Jun 29, 2021
H3682
lotter on DSK11XQN23PROD with BILLS
2 
•HR 3682 IH
(1) in subsection (c), in the matter preceding 
1
paragraph (1), by inserting ‘‘(other than as per-
2
mitted under subsection (e))’’ after ‘‘disclosed by the 
3
Secretary’’; and 
4
(2) by adding at the end the following new sub-
5
section: 
6
‘‘(e) PUBLIC AVAILABILITY OF CERTAIN INFORMA-
7
TION.— 
8
‘‘(1) IN GENERAL.—In order to allow the com-
9
parison of PBMs’ ability to negotiate rebates, dis-
10
counts, direct and indirect remuneration fees, ad-
11
ministrative fees, and price concessions and the 
12
amount of such rebates, discounts, direct and indi-
13
rect remuneration fees, administrative fees, and 
14
price concessions that are passed through to plan 
15
sponsors, beginning January 1, 2022, the Secretary 
16
shall make available on the Internet website of the 
17
Department of Health and Human Services the in-
18
formation with respect to the second preceding cal-
19
endar year provided to the Secretary on generic dis-
20
pensing rates (as described in paragraph (1) of sub-
21
section (b)) and information provided to the Sec-
22
retary under paragraphs (2) and (3) of such sub-
23
section that, as determined by the Secretary, is with 
24
respect to each PBM. 
25
17:16 Jun 29, 2021
H3682
lotter on DSK11XQN23PROD with BILLS
3 
•HR 3682 IH
‘‘(2) AVAILABILITY OF DATA.—In carrying out 
1
paragraph (1), the Secretary shall ensure the fol-
2
lowing: 
3
‘‘(A) CONFIDENTIALITY.—The information 
4
described in such paragraph is displayed in a 
5
manner that prevents the disclosure of informa-
6
tion, with respect to an individual drug or an 
7
individual plan, on rebates, discounts, direct 
8
and indirect remuneration fees, administrative 
9
fees, and price concessions. 
10
‘‘(B) CLASS OF DRUG.—The information 
11
described in such paragraph is made available 
12
by class of drug, using an existing classification 
13
system, but only if the class contains such num-
14
ber of drugs, as specified by the Secretary (but 
15
not fewer than three drugs), to ensure confiden-
16
tiality of proprietary information or other infor-
17
mation that is prevented to be disclosed under 
18
subparagraph (A).’’. 
19
Æ 
17:16 Jun 29, 2021
H3682
lotter on DSK11XQN23PROD with BILLS
